SILDENAFIL POWDER,

SILDENAFIL POWDER, was reported 35874 times

SILDENAFIL POWDER, is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY HYPERTENSIVE CRISIS 71 0.2620
1 DEVICE WIRELESS COMMUNICATION ISSUE 63 0.2432
2 HIGH RISK SEXUAL BEHAVIOUR 43 0.2376
3 HEART AND LUNG TRANSPLANT 21 0.1628
4 DEVICE MAINTENANCE ISSUE 90 0.1531
5 ATRIAL SEPTAL DEFECT REPAIR 25 0.1453
6 TRANSPLANT EVALUATION 68 0.1339
7 CATHETER MANAGEMENT 110 0.1224
8 VENTILATION PERFUSION MISMATCH 31 0.1103
9 RIGHT VENTRICULAR FAILURE 762 0.1086
10 PULMONARY ARTERIAL PRESSURE INCREASED 173 0.1061
11 PULMONARY VENO-OCCLUSIVE DISEASE 74 0.1057
12 PULMONARY ARTERIAL HYPERTENSION 1445 0.0996
13 CATHETER SITE PRURITUS 87 0.0991
14 SUBSTANCE ABUSER 22 0.0969
15 WALKING DISTANCE TEST ABNORMAL 36 0.0921
16 RIGHT VENTRICULAR DILATATION 52 0.0898
17 CATHETER SITE DISCHARGE 99 0.0881
18 CATHETER SITE ERYTHEMA 183 0.0854
19 CATHETER SITE RASH 37 0.0819
20 CARDIOSPASM 43 0.0771
21 RIGHT VENTRICULAR DYSFUNCTION 83 0.0752
22 INFUSION SITE DISCHARGE 132 0.0752
23 OXYGEN CONSUMPTION INCREASED 179 0.0748
24 CATHETERISATION CARDIAC ABNORMAL 20 0.0741
25 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 103 0.0733
26 INFUSION SITE INFECTION 170 0.0731
27 PULMONARY ARTERIAL PRESSURE ABNORMAL 20 0.0694
28 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 22 0.0694
29 CATHETER SITE SWELLING 64 0.0684
30 PARACENTESIS 42 0.0683
31 INFUSION SITE INDURATION 101 0.0681
32 INFUSION SITE IRRITATION 86 0.0669
33 IMMUNISATION 29 0.0668
34 CATHETER SITE IRRITATION 21 0.0631
35 RIGHT VENTRICULAR ENLARGEMENT 20 0.0625
36 HEART TRANSPLANT 56 0.0619
37 LUNG TRANSPLANT 218 0.0615
38 INFUSION SITE INFLAMMATION 43 0.0609
39 PALMOPLANTAR KERATODERMA 43 0.0593
40 INFUSION SITE HAEMORRHAGE 194 0.0589
41 INFUSION SITE WARMTH 72 0.0587
42 INFUSION SITE PAIN 753 0.0584
43 PULMONARY ARTERY DILATATION 20 0.0581
44 INFUSION SITE ERYTHEMA 462 0.0547
45 INFUSION SITE DISCOLOURATION 48 0.0545
46 INFUSION SITE NODULE 52 0.0541
47 DEVICE INFUSION ISSUE 133 0.0536
48 CATHETER SITE PAIN 139 0.0535
49 INFUSION SITE CELLULITIS 28 0.0530
50 SYSTEMIC SCLERODERMA 38 0.0522
51 INFUSION SITE VESICLES 27 0.0513
52 BIOPSY LIVER 21 0.0511
53 PULMONARY HYPERTENSION 1054 0.0505
54 CATHETER SITE INFLAMMATION 27 0.0480
55 INFUSION SITE ABSCESS 24 0.0476
56 INFUSION SITE DISCOMFORT 49 0.0473
57 CATHETERISATION CARDIAC 194 0.0437
58 DEPENDENCE ON OXYGEN THERAPY 21 0.0426
59 INFUSION SITE SWELLING 263 0.0418
60 CATHETER SITE HAEMORRHAGE 102 0.0407
61 DEVICE ALARM ISSUE 73 0.0402
62 INFUSION SITE RASH 55 0.0401
63 RIGHT VENTRICULAR HYPERTROPHY 36 0.0399
64 CHRONIC RESPIRATORY FAILURE 46 0.0381
65 CATHETER PLACEMENT 70 0.0377
66 INFUSION SITE PRURITUS 116 0.0367
67 COR PULMONALE 35 0.0366
68 INFUSION SITE REACTION 108 0.0361
69 SUBSTANCE USE DISORDER 115 0.0361
70 ASPIRATION PLEURAL CAVITY 27 0.0351
71 DYSCHROMATOPSIA 29 0.0350
72 INFUSION SITE OEDEMA 29 0.0347
73 PACKED RED BLOOD CELL TRANSFUSION 45 0.0340
74 ATRIAL TACHYCARDIA 71 0.0338
75 SCLERODERMA 115 0.0316
76 DIZZINESS EXERTIONAL 23 0.0303
77 FLUID OVERLOAD 438 0.0301
78 CATHETER SITE INFECTION 113 0.0298
79 TRACHEOSTOMY 42 0.0294
80 BRAIN NATRIURETIC PEPTIDE INCREASED 90 0.0292
81 OXYGEN THERAPY 47 0.0286
82 BRONCHOPULMONARY DYSPLASIA 23 0.0286
83 INFUSION SITE MASS 31 0.0285
84 CATHETER SITE RELATED REACTION 21 0.0280
85 CENTRAL VENOUS CATHETERISATION 83 0.0275
86 HEPATIC CONGESTION 26 0.0275
87 TRANSFUSION 286 0.0273
88 FINGER AMPUTATION 20 0.0272
89 MECHANICAL VENTILATION 50 0.0263
90 HYPERVOLAEMIA 129 0.0261
91 PAIN IN JAW 723 0.0255
92 DEVICE RELATED SEPSIS 49 0.0243
93 VASCULAR DEVICE INFECTION 109 0.0240
94 TELANGIECTASIA 22 0.0228
95 DYSPNOEA AT REST 66 0.0228
96 CARBON DIOXIDE INCREASED 30 0.0220
97 PURULENT DISCHARGE 94 0.0220
98 CARDIAC ABLATION 39 0.0218
99 FLUID RETENTION 1101 0.0216
100 COUNTERFEIT PRODUCT ADMINISTERED 28 0.0215
101 CONCOMITANT DISEASE AGGRAVATED 132 0.0214
102 DYSPNOEA EXERTIONAL 777 0.0206
103 CARDIOVERSION 28 0.0200
104 EXERCISE TOLERANCE DECREASED 112 0.0194
105 PRIAPISM 67 0.0194
106 DERMATITIS CONTACT 219 0.0192
107 STAPHYLOCOCCUS TEST POSITIVE 40 0.0190
108 PRURITUS GENITAL 44 0.0187
109 CONCOMITANT DISEASE PROGRESSION 36 0.0184
110 ACUTE RESPIRATORY FAILURE 350 0.0182
111 RHINOVIRUS INFECTION 70 0.0180
112 HYPOXIA 621 0.0176
113 DEVICE CONNECTION ISSUE 37 0.0175
114 DEVICE POWER SOURCE ISSUE 51 0.0175
115 DEVICE RELATED INFECTION 268 0.0174
116 OXYGEN SATURATION ABNORMAL 48 0.0169
117 CHORIORETINOPATHY 24 0.0169
118 OXYGEN SATURATION DECREASED 934 0.0166
119 ECHOCARDIOGRAM ABNORMAL 23 0.0164
120 BLOOD CULTURE POSITIVE 48 0.0160
121 SUBSTANCE USE 25 0.0160
122 ORTHOPNOEA 50 0.0157
123 ENDOTRACHEAL INTUBATION 44 0.0157
124 OPTIC ISCHAEMIC NEUROPATHY 59 0.0152
125 CARDIAC OPERATION 130 0.0151
126 INFUSION SITE BRUISING 32 0.0148
127 ANGIOPLASTY 22 0.0147
128 TRANSPLANT 35 0.0147
129 LIVER TRANSPLANT 52 0.0143
130 CARDIAC FAILURE ACUTE 95 0.0142
131 PREMATURE DELIVERY 216 0.0136
132 PULSELESS ELECTRICAL ACTIVITY 55 0.0131
133 ATRIAL FLUTTER 103 0.0129
134 THROMBOSIS IN DEVICE 42 0.0128
135 RETINAL ARTERY OCCLUSION 32 0.0127
136 CAROTID ARTERY OCCLUSION 46 0.0126
137 CYANOSIS 197 0.0125
138 RESPIRATORY TRACT INFECTION VIRAL 29 0.0124
139 LOCALISED OEDEMA 57 0.0123
140 CARDIAC FAILURE CHRONIC 52 0.0122
141 TENSION HEADACHE 52 0.0121
142 HAEMOGLOBIN INCREASED 55 0.0120
143 LEFT VENTRICULAR FAILURE 41 0.0119
144 PULMONARY OEDEMA 531 0.0118
145 RETINAL VEIN OCCLUSION 34 0.0118
146 DISEASE COMPLICATION 54 0.0118
147 CARDIAC PACEMAKER INSERTION 70 0.0117
148 POLYCYTHAEMIA 24 0.0116
149 PULMONARY PAIN 33 0.0113
150 OEDEMA 613 0.0113
151 PERICARDIAL EFFUSION 259 0.0112
152 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 69 0.0112
153 INTRA-ABDOMINAL FLUID COLLECTION 20 0.0112
154 VASODILATATION 28 0.0111
155 SLEEP TERROR 45 0.0107
156 HYPERCAPNIA 32 0.0106
157 DIZZINESS POSTURAL 103 0.0106
158 BLOOD PRESSURE DIASTOLIC ABNORMAL 27 0.0106
159 DEVICE OCCLUSION 147 0.0104
160 NASAL CONGESTION 612 0.0104
161 HERNIA REPAIR 27 0.0104
162 SEASONAL ALLERGY 146 0.0103
163 SUBARACHNOID HAEMORRHAGE 105 0.0103
164 PRODUCT ADMINISTRATION INTERRUPTED 80 0.0102
165 MACULOPATHY 36 0.0101
166 HAEMATOCRIT INCREASED 23 0.0101
167 TACHYARRHYTHMIA 25 0.0100
168 SUDDEN CARDIAC DEATH 34 0.0100
169 EJACULATION FAILURE 20 0.0100
170 TRICUSPID VALVE INCOMPETENCE 79 0.0099
171 PREMATURE BABY 297 0.0099
172 CARDIOPULMONARY FAILURE 38 0.0097
173 PULMONARY HAEMORRHAGE 74 0.0095
174 CARDIAC DISCOMFORT 19 0.0094
175 RESPIRATORY SYNCYTIAL VIRUS INFECTION 82 0.0094
176 BLOOD PRESSURE SYSTOLIC ABNORMAL 23 0.0093
177 RESPIRATORY FAILURE 674 0.0092
178 CARDIAC FAILURE 736 0.0092
179 THERAPY CHANGE 90 0.0091
180 ASCITES 269 0.0091
181 DIALYSIS 129 0.0091
182 DEVICE FAILURE 137 0.0090
183 RESPIRATION ABNORMAL 62 0.0090
184 CARDIOGENIC SHOCK 129 0.0090
185 COMPARTMENT SYNDROME 23 0.0088
186 HAEMODYNAMIC INSTABILITY 67 0.0088
187 HYPERPARATHYROIDISM SECONDARY 22 0.0088
188 THERAPY NON-RESPONDER 392 0.0087
189 ERECTILE DYSFUNCTION 223 0.0087
190 PULMONARY ALVEOLAR HAEMORRHAGE 48 0.0085
191 SYNCOPE 843 0.0084
192 CARDIAC TAMPONADE 40 0.0084
193 GASTROINTESTINAL TUBE INSERTION 21 0.0084
194 HEART VALVE INCOMPETENCE 24 0.0084
195 SUSPECTED COUNTERFEIT PRODUCT 33 0.0083
196 CARDIOMEGALY 102 0.0083
197 VIRAL UPPER RESPIRATORY TRACT INFECTION 39 0.0082
198 LOW BIRTH WEIGHT BABY 65 0.0082
199 IDIOPATHIC PULMONARY FIBROSIS 32 0.0081
200 DYSPNOEA 4515 0.0080
201 PULMONARY CONGESTION 105 0.0080
202 HAEMOPTYSIS 217 0.0078
203 FACIAL PAIN 69 0.0077
204 BLOOD PRESSURE SYSTOLIC DECREASED 35 0.0077
205 NEPHROGENIC ANAEMIA 35 0.0075
206 OEDEMA PERIPHERAL 915 0.0075
207 PRODUCT LEAKAGE 42 0.0075
208 DEVICE KINK 27 0.0074
209 PARANASAL SINUS DISCOMFORT 28 0.0074
210 CHOKING SENSATION 40 0.0072
211 AMMONIA INCREASED 37 0.0072
212 RESPIRATORY DISTRESS 199 0.0072
213 DIASTOLIC DYSFUNCTION 22 0.0071
214 NEONATAL RESPIRATORY DISTRESS SYNDROME 25 0.0071
215 INJECTION SITE INFECTION 23 0.0070
216 FLUSHING 707 0.0069
217 CARDIAC FAILURE CONGESTIVE 555 0.0069
218 PRESYNCOPE 167 0.0069
219 HYPOTENSION 1371 0.0068
220 PARANASAL SINUS HYPERSECRETION 26 0.0068
221 SUDDEN DEATH 72 0.0068
222 PRODUCT CONTAMINATION 24 0.0067
223 RALES 39 0.0067
224 INJECTION SITE DISCHARGE 36 0.0067
225 CIRCULATORY COLLAPSE 113 0.0066
226 IRON DEFICIENCY ANAEMIA 61 0.0066
227 GOUT 118 0.0066
228 TROPONIN INCREASED 50 0.0066
229 BLOOD PRESSURE DIASTOLIC INCREASED 30 0.0065
230 PORTAL HYPERTENSION 20 0.0065
231 POLYURIA 53 0.0065
232 CONJUNCTIVAL HYPERAEMIA 23 0.0064
233 STAPHYLOCOCCAL BACTERAEMIA 28 0.0064
234 FOETAL GROWTH RESTRICTION 39 0.0064
235 COMPLICATION ASSOCIATED WITH DEVICE 92 0.0063
236 INTERNATIONAL NORMALISED RATIO DECREASED 25 0.0062
237 SELF-MEDICATION 25 0.0061
238 CHEMOTHERAPY 23 0.0061
239 STENT PLACEMENT 49 0.0061
240 BACTERAEMIA 72 0.0061
241 ERECTION INCREASED 25 0.0060
242 INFUSION SITE EXTRAVASATION 37 0.0059
243 LUNG DISORDER 291 0.0059
244 NASAL DRYNESS 37 0.0059
245 EPISTAXIS 441 0.0059
246 DEVICE DISLOCATION 256 0.0059
247 STAPHYLOCOCCAL SEPSIS 29 0.0059
248 PNEUMOTHORAX 93 0.0059
249 MIOSIS 47 0.0059
250 RESPIRATORY ACIDOSIS 23 0.0058
251 LEFT VENTRICULAR HYPERTROPHY 25 0.0058
252 CONGESTIVE CARDIOMYOPATHY 24 0.0058
253 ASPHYXIA 47 0.0058
254 CHEST PAIN 1059 0.0057
255 ACUTE PULMONARY OEDEMA 32 0.0057
256 PRODUCTIVE COUGH 272 0.0057
257 VENTRICULAR TACHYCARDIA 94 0.0057
258 GENERALISED OEDEMA 70 0.0056
259 INCORRECT DRUG ADMINISTRATION RATE 24 0.0056
260 PLEURAL EFFUSION 343 0.0056
261 HAEMATOCRIT DECREASED 111 0.0056
262 FAILURE TO THRIVE 29 0.0056
263 HOSPICE CARE 55 0.0056
264 IRON DEFICIENCY 25 0.0056
265 BLOOD BILIRUBIN INCREASED 150 0.0055
266 INTERNAL HAEMORRHAGE 63 0.0055
267 AORTIC STENOSIS 19 0.0055
268 SUPRAVENTRICULAR TACHYCARDIA 52 0.0054
269 CARDIAC FLUTTER 35 0.0054
270 UPPER RESPIRATORY TRACT INFECTION 250 0.0054
271 HEPATOMEGALY 53 0.0054
272 BLOOD POTASSIUM DECREASED 161 0.0053
273 PERIPHERAL SWELLING 824 0.0053
274 VASCULITIS 62 0.0053
275 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 277 0.0053
276 ONYCHOMYCOSIS 23 0.0052
277 PNEUMONIA 1681 0.0052
278 PALPITATIONS 603 0.0051
279 VIRAL INFECTION 171 0.0051
280 DISEASE PROGRESSION 605 0.0051
281 PRODUCT SUPPLY ISSUE 36 0.0050
282 HEART RATE ABNORMAL 28 0.0050
283 CARDIAC ARREST 414 0.0050
284 MULTIPLE ALLERGIES 39 0.0050
285 BLOOD IRON DECREASED 59 0.0050
286 SINUS CONGESTION 67 0.0050
287 LIVER FUNCTION TEST ABNORMAL 144 0.0049
288 HEPATIC CIRRHOSIS 92 0.0049
289 PULMONARY THROMBOSIS 53 0.0049
290 LEG AMPUTATION 20 0.0048
291 SARCOIDOSIS 23 0.0048
292 DECREASED ACTIVITY 52 0.0048
293 CHEST DISCOMFORT 492 0.0048
294 SKIN INFECTION 53 0.0047
295 LOCALISED INFECTION 114 0.0047
296 BLOOD ALKALINE PHOSPHATASE INCREASED 117 0.0047
297 URINE OUTPUT DECREASED 41 0.0047
298 ATRIAL FIBRILLATION 456 0.0047
299 ATELECTASIS 45 0.0047
300 HEADACHE 2910 0.0046
301 TERMINAL STATE 31 0.0046
302 ANOSMIA 67 0.0046
303 RESPIRATORY DISORDER 138 0.0046
304 HEPATIC ENCEPHALOPATHY 43 0.0046
305 SINUS DISORDER 91 0.0046
306 RESPIRATORY TRACT CONGESTION 73 0.0046
307 ISCHAEMIA 21 0.0046
308 CONDITION AGGRAVATED 1389 0.0046
309 LIVER FUNCTION TEST INCREASED 98 0.0046
310 HOSPITALISATION 699 0.0045
311 COUGH 1263 0.0045
312 RESPIRATORY TRACT INFECTION 117 0.0045
313 CLOSTRIDIUM DIFFICILE INFECTION 97 0.0044
314 CARDIO-RESPIRATORY ARREST 185 0.0044
315 TACHYPNOEA 60 0.0044
316 CELLULITIS 221 0.0044
317 GASTROENTERITIS VIRAL 79 0.0044
318 BLOOD LACTIC ACID INCREASED 23 0.0044
319 CORONARY ARTERIAL STENT INSERTION 22 0.0043
320 BLOOD URIC ACID INCREASED 25 0.0043
321 SECRETION DISCHARGE 54 0.0043
322 MENTAL STATUS CHANGES 119 0.0043
323 BLOOD PRESSURE DECREASED 284 0.0043
324 ABNORMAL LOSS OF WEIGHT 29 0.0042
325 PRODUCT DOSE OMISSION 276 0.0042
326 PULMONARY FIBROSIS 81 0.0042
327 CARDIAC VALVE DISEASE 24 0.0042
328 BLOOD UREA INCREASED 70 0.0042
329 LIMB OPERATION 20 0.0042
330 VISUAL FIELD DEFECT 30 0.0041
331 SLEEP APNOEA SYNDROME 79 0.0041
332 SEPSIS 461 0.0041
333 MULTIPLE ORGAN DYSFUNCTION SYNDROME 117 0.0041
334 END STAGE RENAL DISEASE 75 0.0041
335 SPUTUM DISCOLOURED 39 0.0041
336 UPPER GASTROINTESTINAL HAEMORRHAGE 69 0.0041
337 HEART RATE INCREASED 406 0.0041
338 EAR DISCOMFORT 42 0.0041
339 TACHYCARDIA 363 0.0041
340 BLOOD PRESSURE ABNORMAL 81 0.0041
341 VARICOSE VEIN 21 0.0041
342 SKIN ULCER 105 0.0041
343 BREATH SOUNDS ABNORMAL 20 0.0041
344 PROCEDURAL COMPLICATION 31 0.0040
345 PHOTOPHOBIA 76 0.0040
346 HYPERNATRAEMIA 20 0.0040
347 DEVICE LEAKAGE 174 0.0040
348 ASPARTATE AMINOTRANSFERASE INCREASED 213 0.0040
349 EMBOLISM 33 0.0040
350 ELECTROLYTE IMBALANCE 46 0.0040
351 BRAIN FOG 62 0.0040
352 SKIN LACERATION 43 0.0040
353 HEAD INJURY 125 0.0039
354 FLANK PAIN 37 0.0039
355 HYPOVOLAEMIA 23 0.0039
356 HAEMODIALYSIS 33 0.0039
357 PETECHIAE 41 0.0039
358 ACIDOSIS 30 0.0039
359 LOWER GASTROINTESTINAL HAEMORRHAGE 29 0.0039
360 THERAPY PARTIAL RESPONDER 61 0.0039
361 INFLUENZA 436 0.0039
362 PREMATURE LABOUR 22 0.0039
363 UNINTENTIONAL MEDICAL DEVICE REMOVAL 45 0.0039
364 HAEMOGLOBIN DECREASED 399 0.0039
365 MUSCULOSKELETAL CHEST PAIN 60 0.0039
366 SINUS HEADACHE 23 0.0039
367 ISCHAEMIC STROKE 69 0.0039
368 UNEVALUABLE EVENT 292 0.0039
369 LUNG INFILTRATION 34 0.0038
370 HEAD DISCOMFORT 68 0.0038
371 THERAPY CESSATION 197 0.0038
372 RESPIRATORY RATE INCREASED 34 0.0038
373 HAEMATEMESIS 97 0.0038
374 LUNG INFECTION 59 0.0038
375 SUBDURAL HAEMATOMA 54 0.0038
376 ALANINE AMINOTRANSFERASE INCREASED 230 0.0037
377 LIGAMENT SPRAIN 37 0.0037
378 SWELLING 350 0.0037
379 FOOD POISONING 20 0.0037
380 PELVIC FRACTURE 29 0.0037
381 BLOOD MAGNESIUM DECREASED 32 0.0037
382 TRANSIENT ISCHAEMIC ATTACK 125 0.0037
383 COMA 176 0.0037
384 CAESAREAN SECTION 43 0.0037
385 ABDOMINAL DISTENSION 385 0.0037
386 MOUTH HAEMORRHAGE 27 0.0037
387 NORMAL NEWBORN 20 0.0037
388 CARDIAC DISORDER 344 0.0037
389 GASTROINTESTINAL HAEMORRHAGE 307 0.0037
390 DIARRHOEA 2360 0.0037
391 DEVICE PHYSICAL PROPERTY ISSUE 28 0.0037
392 NEPHROPATHY 34 0.0036
393 MYALGIA 617 0.0036
394 DIZZINESS 1808 0.0036
395 UNRESPONSIVE TO STIMULI 93 0.0036
396 IMPAIRED GASTRIC EMPTYING 49 0.0036
397 MUSCLE STRAIN 31 0.0036
398 BRADYCARDIA 189 0.0036
399 ASPIRATION 39 0.0036
400 HYPOKALAEMIA 164 0.0035
401 ACUTE KIDNEY INJURY 541 0.0035
402 DRUG ABUSE 294 0.0035
403 TREATMENT NONCOMPLIANCE 193 0.0035
404 ARTHROPOD BITE 26 0.0035
405 SMALL INTESTINAL OBSTRUCTION 43 0.0035
406 MYOPATHY 30 0.0035
407 MELAENA 76 0.0034
408 DRUG USE DISORDER 29 0.0034
409 SUBSTANCE ABUSE 28 0.0034
410 LOSS OF CONSCIOUSNESS 438 0.0034
411 PALLOR 93 0.0034
412 BLOOD CREATININE INCREASED 223 0.0034
413 NASAL DISCOMFORT 27 0.0034
414 RIB FRACTURE 70 0.0034
415 INTERNATIONAL NORMALISED RATIO INCREASED 97 0.0034
416 BLOOD SODIUM DECREASED 64 0.0034
417 LIP SWELLING 113 0.0034
418 PAIN IN EXTREMITY 998 0.0034
419 BRONCHITIS 250 0.0034
420 FOETAL EXPOSURE DURING PREGNANCY 273 0.0034
421 GASTROENTERITIS 49 0.0034
422 DIPLOPIA 87 0.0033
423 STAPHYLOCOCCAL INFECTION 110 0.0033
424 INTENTIONAL DOSE OMISSION 95 0.0033
425 GENERALISED TONIC-CLONIC SEIZURE 55 0.0033
426 LARGE INTESTINE POLYP 23 0.0033
427 SHOCK HAEMORRHAGIC 27 0.0033
428 FAECES SOFT 24 0.0033
429 ANAEMIA 628 0.0033
430 HOT FLUSH 248 0.0033
431 EXPOSURE DURING PREGNANCY 204 0.0033
432 POST PROCEDURAL COMPLICATION 63 0.0033
433 PERICARDITIS 55 0.0033
434 PNEUMONIA BACTERIAL 30 0.0033
435 SEPTIC SHOCK 142 0.0033
436 ANURIA 28 0.0033
437 WEIGHT FLUCTUATION 34 0.0032
438 HEART RATE IRREGULAR 73 0.0032
439 OLIGURIA 20 0.0032
440 TINNITUS 148 0.0032
441 COVID-19 PNEUMONIA 38 0.0032
442 DEAFNESS 84 0.0032
443 CLOSTRIDIUM DIFFICILE COLITIS 34 0.0032
444 BLOOD POTASSIUM INCREASED 52 0.0032
445 NO THERAPEUTIC RESPONSE 39 0.0032
446 EAR INFECTION 85 0.0032
447 ELECTROCARDIOGRAM ABNORMAL 25 0.0032
448 HYPERBILIRUBINAEMIA 33 0.0032
449 RENAL FAILURE 422 0.0032
450 EMPHYSEMA 32 0.0032
451 ACUTE RESPIRATORY DISTRESS SYNDROME 56 0.0032
452 DEATH 2711 0.0031
453 OBSTRUCTIVE AIRWAYS DISORDER 35 0.0031
454 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
455 LIPASE INCREASED 24 0.0031
456 ANAL INCONTINENCE 28 0.0031
457 DEHYDRATION 415 0.0031
458 MEDICAL DEVICE COMPLICATION 23 0.0031
459 DECREASED APPETITE 722 0.0031
460 HYPERTHYROIDISM 45 0.0031
461 RETCHING 66 0.0031
462 RHINORRHOEA 200 0.0031
463 FAECES DISCOLOURED 67 0.0031
464 ACUTE MYOCARDIAL INFARCTION 91 0.0031
465 APNOEA 24 0.0031
466 CHOLECYSTECTOMY 35 0.0031
467 VENTRICULAR FIBRILLATION 34 0.0031
468 NASOPHARYNGITIS 563 0.0031
469 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27 0.0031
470 BEDRIDDEN 40 0.0030
471 CHRONIC KIDNEY DISEASE 231 0.0030
472 MYDRIASIS 39 0.0030
473 INTERSTITIAL LUNG DISEASE 147 0.0030
474 SINUS TACHYCARDIA 43 0.0030
475 NEUTROPHIL COUNT INCREASED 31 0.0030
476 CHOKING 59 0.0030
477 VOMITING 1420 0.0030
478 BLINDNESS 123 0.0030
479 BACTERIAL INFECTION 56 0.0030
480 ABDOMINAL DISCOMFORT 498 0.0030
481 BLOOD COUNT ABNORMAL 45 0.0030
482 POSTOPERATIVE WOUND INFECTION 20 0.0030
483 ORTHOSTATIC HYPOTENSION 51 0.0029
484 WEIGHT DECREASED 817 0.0029
485 RESTLESS LEGS SYNDROME 53 0.0029
486 ARRHYTHMIA 138 0.0029
487 HYPOTONIA 29 0.0029
488 COAGULOPATHY 48 0.0029
489 RENAL DISORDER 134 0.0029
490 SYSTEMIC LUPUS ERYTHEMATOSUS 102 0.0029
491 BOWEL MOVEMENT IRREGULARITY 22 0.0029
492 LIMB INJURY 78 0.0029
493 OROPHARYNGEAL PAIN 265 0.0029
494 THROAT IRRITATION 128 0.0028
495 GROIN PAIN 25 0.0028
496 PNEUMONIA ASPIRATION 71 0.0028
497 CONCUSSION 22 0.0028
498 ATRIOVENTRICULAR BLOCK COMPLETE 19 0.0028
499 GENERAL PHYSICAL HEALTH DETERIORATION 328 0.0028
500 POST PROCEDURAL HAEMORRHAGE 33 0.0028
501 LETHARGY 163 0.0028
502 EYE INFLAMMATION 27 0.0028
503 MALAISE 1241 0.0028
504 GASTROOESOPHAGEAL REFLUX DISEASE 227 0.0028
505 HEART RATE DECREASED 99 0.0028
506 DYSPEPSIA 277 0.0028
507 BRONCHOSPASM 40 0.0028
508 PSEUDOMONAS INFECTION 24 0.0028
509 NAUSEA 2214 0.0028
510 CEREBRAL HAEMORRHAGE 100 0.0028
511 SWELLING FACE 181 0.0028
512 FATIGUE 2164 0.0028
513 HEMIPARESIS 47 0.0028
514 HYSTERECTOMY 24 0.0028
515 PERIPHERAL COLDNESS 38 0.0028
516 WEIGHT INCREASED 617 0.0028
517 TOOTH INFECTION 36 0.0027
518 FALL 907 0.0027
519 RECTAL HAEMORRHAGE 117 0.0027
520 BACK PAIN 632 0.0027
521 SNEEZING 61 0.0027
522 FLATULENCE 154 0.0027
523 MIGRAINE 259 0.0027
524 OVARIAN CYST 27 0.0027
525 WHEEZING 160 0.0027
526 FACIAL PARALYSIS 23 0.0027
527 SPINAL FRACTURE 54 0.0027
528 CHOLECYSTITIS 32 0.0027
529 LOSS OF LIBIDO 24 0.0027
530 ANGINA PECTORIS 76 0.0026
531 PYREXIA 917 0.0026
532 ANKLE FRACTURE 41 0.0026
533 DEVICE USE ERROR 92 0.0026
534 JAUNDICE 71 0.0026
535 MYOCARDIAL ISCHAEMIA 30 0.0026
536 DRUG INTERACTION 416 0.0026
537 GAMMA-GLUTAMYLTRANSFERASE INCREASED 58 0.0026
538 HIP FRACTURE 84 0.0026
539 HIP ARTHROPLASTY 40 0.0026
540 OCULAR DISCOMFORT 29 0.0026
541 ORAL CANDIDIASIS 34 0.0026
542 ABDOMINAL PAIN UPPER 528 0.0026
543 HAEMORRHOIDS 50 0.0026
544 MUSCULOSKELETAL DISCOMFORT 44 0.0026
545 HAEMORRHAGE INTRACRANIAL 38 0.0025
546 ASTHENIA 949 0.0025
547 LIMB DISCOMFORT 78 0.0025
548 HYPOGLYCAEMIA 122 0.0025
549 FEELING COLD 70 0.0025
550 GASTROINTESTINAL DISORDER 224 0.0025
551 BRAIN INJURY 25 0.0025
552 VISUAL IMPAIRMENT 307 0.0025
553 FRUSTRATION TOLERANCE DECREASED 20 0.0025
554 MITRAL VALVE INCOMPETENCE 28 0.0025
555 ANHEDONIA 65 0.0025
556 ANGIOEDEMA 109 0.0025
557 TOOTH ABSCESS 25 0.0025
558 TUBULOINTERSTITIAL NEPHRITIS 46 0.0025
559 DEVICE ISSUE 220 0.0025
560 HYPERKALAEMIA 86 0.0024
561 DRUG INTOLERANCE 236 0.0024
562 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 134 0.0024
563 HYPERSOMNIA 70 0.0024
564 RENAL IMPAIRMENT 205 0.0024
565 LIVER DISORDER 108 0.0024
566 THERAPY INTERRUPTED 174 0.0024
567 MUSCLE TWITCHING 56 0.0024
568 CARDIAC MURMUR 21 0.0024
569 FEELING ABNORMAL 581 0.0024
570 CHILLS 284 0.0024
571 SPINAL COMPRESSION FRACTURE 20 0.0024
572 PULMONARY MASS 36 0.0024
573 NECK PAIN 135 0.0024
574 TOOTH EXTRACTION 30 0.0024
575 UPPER LIMB FRACTURE 48 0.0024
576 AGEUSIA 60 0.0024
577 BLOOD ALBUMIN DECREASED 19 0.0024
578 RESPIRATORY ARREST 66 0.0024
579 LIVE BIRTH 20 0.0024
580 MUSCULOSKELETAL PAIN 125 0.0024
581 BRAIN OEDEMA 30 0.0024
582 HAEMORRHAGE 248 0.0024
583 POOR QUALITY SLEEP 51 0.0024
584 APPENDICITIS 22 0.0024
585 PHARYNGEAL SWELLING 23 0.0023
586 CHROMATURIA 53 0.0023
587 DIVERTICULITIS 65 0.0023
588 HAEMOLYTIC ANAEMIA 21 0.0023
589 KNEE OPERATION 23 0.0023
590 BLOOD PRESSURE FLUCTUATION 56 0.0023
591 PRODUCT USE ISSUE 438 0.0023
592 PRODUCT SUBSTITUTION ISSUE 134 0.0023
593 ABDOMINAL PAIN 541 0.0023
594 MALNUTRITION 26 0.0023
595 MULTI-ORGAN FAILURE 40 0.0023
596 POISONING 29 0.0023
597 PAIN OF SKIN 62 0.0023
598 RHABDOMYOLYSIS 96 0.0023
599 MATERNAL EXPOSURE DURING PREGNANCY 205 0.0023
600 INTESTINAL OBSTRUCTION 86 0.0023
601 GASTRITIS 60 0.0023
602 RED BLOOD CELL COUNT DECREASED 65 0.0023
603 ATRIAL SEPTAL DEFECT 19 0.0023
604 DRY THROAT 23 0.0023
605 ULCER 36 0.0023
606 GASTRIC HAEMORRHAGE 26 0.0023
607 SLUGGISHNESS 23 0.0023
608 DYSURIA 83 0.0023
609 MANIA 37 0.0022
610 HERPES ZOSTER 129 0.0022
611 RENAL TUBULAR NECROSIS 22 0.0022
612 THIRST 40 0.0022
613 HAEMATOMA 58 0.0022
614 DEVICE MALFUNCTION 157 0.0022
615 GASTROINTESTINAL INFECTION 20 0.0022
616 IMPAIRED QUALITY OF LIFE 32 0.0022
617 MUSCULAR WEAKNESS 251 0.0022
618 POLLAKIURIA 92 0.0022
619 URINARY TRACT INFECTION 376 0.0022
620 INFECTION 319 0.0022
621 TRANSAMINASES INCREASED 49 0.0022
622 C-REACTIVE PROTEIN INCREASED 80 0.0022
623 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
624 CHOLELITHIASIS 72 0.0022
625 KIDNEY INFECTION 43 0.0022
626 SCRATCH 23 0.0022
627 INCREASED TENDENCY TO BRUISE 20 0.0022
628 BODY TEMPERATURE INCREASED 44 0.0022
629 AGITATION 158 0.0021
630 HEPATIC STEATOSIS 40 0.0021
631 HAEMATOCHEZIA 118 0.0021
632 FEELING HOT 131 0.0021
633 OBESITY 34 0.0021
634 ACCIDENTAL OVERDOSE 78 0.0021
635 TEMPERATURE INTOLERANCE 22 0.0021
636 LACERATION 20 0.0021
637 PHARYNGITIS STREPTOCOCCAL 23 0.0021
638 DRUG DOSE OMISSION 351 0.0021
639 SARS-COV-2 TEST POSITIVE 28 0.0021
640 COGNITIVE DISORDER 99 0.0021
641 BACK INJURY 23 0.0021
642 DRUG LEVEL INCREASED 35 0.0021
643 OSTEOPENIA 32 0.0021
644 THROMBOSIS 169 0.0021
645 GALLBLADDER DISORDER 37 0.0021
646 JOINT INJURY 44 0.0021
647 WHITE BLOOD CELL COUNT INCREASED 79 0.0021
648 BLOOD URINE PRESENT 39 0.0021
649 LOWER RESPIRATORY TRACT INFECTION 93 0.0020
650 CARDIOMYOPATHY 30 0.0020
651 HEPATIC FAILURE 61 0.0020
652 PHARYNGITIS 25 0.0020
653 OESOPHAGITIS 22 0.0020
654 ANXIETY 572 0.0020
655 SCIATICA 32 0.0020
656 EAR PAIN 39 0.0020
657 HYPERHIDROSIS 258 0.0020
658 MUSCLE SPASMS 367 0.0020
659 HYPOACUSIS 86 0.0020
660 FEELING JITTERY 38 0.0020
661 EYE PRURITUS 67 0.0020
662 VISION BLURRED 273 0.0020
663 SCAR 34 0.0020
664 BLINDNESS UNILATERAL 28 0.0020
665 DYSPHONIA 116 0.0020
666 INSOMNIA 527 0.0020
667 HYPOTHERMIA 20 0.0020
668 NEURALGIA 48 0.0020
669 PARANOIA 34 0.0020
670 DRY MOUTH 160 0.0020
671 HERNIA 38 0.0020
672 ILLNESS 201 0.0019
673 EYE HAEMORRHAGE 26 0.0019
674 EYE INFECTION 22 0.0019
675 QUALITY OF LIFE DECREASED 26 0.0019
676 COLD SWEAT 34 0.0019
677 PULMONARY EMBOLISM 182 0.0019
678 LIVER INJURY 47 0.0019
679 ARTHRALGIA 796 0.0019
680 MEMORY IMPAIRMENT 263 0.0019
681 SINUSITIS 195 0.0019
682 ACUTE HEPATIC FAILURE 26 0.0019
683 FOOT FRACTURE 36 0.0019
684 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0019
685 INTENTIONAL PRODUCT USE ISSUE 166 0.0019
686 ALTERED STATE OF CONSCIOUSNESS 41 0.0019
687 COVID-19 332 0.0019
688 JOINT DISLOCATION 20 0.0019
689 DEVICE USE ISSUE 33 0.0019
690 HEPATOTOXICITY 42 0.0019
691 OSTEOMYELITIS 34 0.0019
692 TOXICITY TO VARIOUS AGENTS 316 0.0019
693 PAIN 1151 0.0019
694 LOWER LIMB FRACTURE 36 0.0019
695 RASH MACULAR 65 0.0019
696 HIATUS HERNIA 24 0.0019
697 CONSTIPATION 404 0.0019
698 CORONARY ARTERY DISEASE 56 0.0018
699 AMNESIA 120 0.0018
700 BLOOD CREATINE PHOSPHOKINASE INCREASED 53 0.0018
701 PLATELET COUNT INCREASED 24 0.0018
702 MICTURITION URGENCY 21 0.0018
703 DISTURBANCE IN ATTENTION 99 0.0018
704 GINGIVAL BLEEDING 25 0.0018
705 LACRIMATION INCREASED 55 0.0018
706 SEIZURE 210 0.0018
707 DRUG-INDUCED LIVER INJURY 57 0.0018
708 OCULAR HYPERAEMIA 86 0.0018
709 PLATELET COUNT DECREASED 193 0.0018
710 SKIN DISCOLOURATION 83 0.0018
711 JOINT SWELLING 218 0.0018
712 NERVE INJURY 20 0.0018
713 PREGNANCY 36 0.0018
714 HYPOMAGNESAEMIA 25 0.0018
715 INTENTIONAL PRODUCT MISUSE 157 0.0018
716 APHONIA 25 0.0018
717 TREMOR 297 0.0018
718 VERTIGO 109 0.0018
719 HYPERTENSION 378 0.0018
720 METABOLIC ACIDOSIS 57 0.0018
721 DYSSTASIA 52 0.0018
722 THROMBOCYTOPENIA 199 0.0018
723 FACE OEDEMA 30 0.0018
724 GASTRIC DISORDER 61 0.0018
725 HYPONATRAEMIA 100 0.0018
726 FEEDING DISORDER 36 0.0018
727 SKIN REACTION 25 0.0018
728 TASTE DISORDER 36 0.0018
729 EYE SWELLING 66 0.0018
730 SEROTONIN SYNDROME 34 0.0018
731 SURGERY 103 0.0018
732 ABSCESS 28 0.0018
733 DIABETES MELLITUS INADEQUATE CONTROL 31 0.0017
734 DERMATITIS ALLERGIC 22 0.0017
735 SHOCK 40 0.0017
736 LABORATORY TEST ABNORMAL 51 0.0017
737 CYSTITIS 55 0.0017
738 DEPRESSED MOOD 91 0.0017
739 LOCAL SWELLING 30 0.0017
740 ECONOMIC PROBLEM 26 0.0017
741 SLEEP DISORDER 121 0.0017
742 CARPAL TUNNEL SYNDROME 24 0.0017
743 ROTATOR CUFF SYNDROME 22 0.0017
744 ENCEPHALOPATHY 42 0.0017
745 ERYTHEMA 351 0.0017
746 SPLENOMEGALY 20 0.0017
747 GAIT DISTURBANCE 326 0.0017
748 PANCREATITIS ACUTE 38 0.0017
749 SOMNOLENCE 340 0.0017
750 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 81 0.0017
751 CONTUSION 162 0.0017
752 HYPOPHAGIA 43 0.0017
753 COLON CANCER 25 0.0017
754 NIGHT SWEATS 54 0.0017
755 DEVICE BREAKAGE 68 0.0017
756 MUSCLE TIGHTNESS 27 0.0017
757 BASAL CELL CARCINOMA 26 0.0017
758 CONFUSIONAL STATE 269 0.0017
759 TOOTHACHE 30 0.0017
760 NOCTURIA 20 0.0016
761 RASH PRURITIC 89 0.0016
762 DISCOMFORT 100 0.0016
763 BLOOD TEST ABNORMAL 23 0.0016
764 SWOLLEN TONGUE 51 0.0016
765 OFF LABEL USE 1427 0.0016
766 MENORRHAGIA 32 0.0016
767 ROAD TRAFFIC ACCIDENT 68 0.0016
768 IMMUNODEFICIENCY 24 0.0016
769 LEUKOCYTOSIS 29 0.0016
770 ARTHRITIS 126 0.0016
771 NEPHROLITHIASIS 73 0.0016
772 DISORIENTATION 63 0.0016
773 APHASIA 48 0.0016
774 GAIT INABILITY 53 0.0016
775 PRODUCT ADMINISTRATION ERROR 32 0.0016
776 MYOCARDIAL INFARCTION 276 0.0016
777 LYMPHADENOPATHY 56 0.0016
778 HALLUCINATION 119 0.0016
779 DEMENTIA 44 0.0016
780 WOUND 44 0.0016
781 EYE PAIN 88 0.0016
782 OSTEOPOROSIS 64 0.0016
783 HEPATIC ENZYME INCREASED 106 0.0016
784 ERUCTATION 30 0.0015
785 HAEMATURIA 53 0.0015
786 BLOOD PRESSURE INCREASED 236 0.0015
787 PANIC ATTACK 56 0.0015
788 PANCYTOPENIA 85 0.0015
789 PHOTOSENSITIVITY REACTION 25 0.0015
790 NERVOUSNESS 79 0.0015
791 GLAUCOMA 29 0.0015
792 INSURANCE ISSUE 23 0.0015
793 MENTAL DISORDER 65 0.0015
794 MALIGNANT MELANOMA 20 0.0015
795 THYROID DISORDER 23 0.0015
796 GYNAECOMASTIA 46 0.0015
797 BURNING SENSATION 104 0.0015
798 RENAL INJURY 44 0.0015
799 EJECTION FRACTION DECREASED 23 0.0015
800 HYPOCALCAEMIA 28 0.0015
801 THROAT TIGHTNESS 40 0.0015
802 BACK DISORDER 24 0.0015
803 GASTRIC ULCER 28 0.0015
804 KNEE ARTHROPLASTY 31 0.0015
805 INFLUENZA LIKE ILLNESS 121 0.0015
806 PARAESTHESIA ORAL 21 0.0015
807 BONE PAIN 85 0.0014
808 RESTLESSNESS 53 0.0014
809 HYPOKINESIA 21 0.0014
810 CEREBROVASCULAR ACCIDENT 244 0.0014
811 APATHY 21 0.0014
812 OSTEOARTHRITIS 61 0.0014
813 DEVICE ADHESION ISSUE 22 0.0014
814 RASH PAPULAR 32 0.0014
815 MOUTH ULCERATION 30 0.0014
816 PRODUCT PRESCRIBING ISSUE 31 0.0014
817 URINARY INCONTINENCE 42 0.0014
818 DRUG EFFECT LESS THAN EXPECTED 21 0.0014
819 BLISTER 79 0.0014
820 COLITIS 53 0.0014
821 MOOD ALTERED 38 0.0014
822 CEREBRAL INFARCTION 34 0.0014
823 HYPOAESTHESIA 208 0.0014
824 ABDOMINAL PAIN LOWER 35 0.0014
825 CATARACT 82 0.0014
826 CONTRAINDICATED PRODUCT ADMINISTERED 41 0.0014
827 CHOLESTASIS 26 0.0014
828 DRUG INEFFECTIVE 1783 0.0014
829 SKIN DISORDER 45 0.0013
830 RENAL FAILURE ACUTE 57 0.0013
831 PARAESTHESIA 211 0.0013
832 INTENTIONAL OVERDOSE 86 0.0013
833 AGGRESSION 67 0.0013
834 DYSPHAGIA 127 0.0013
835 DELIRIUM 46 0.0013
836 ADVERSE EVENT 122 0.0013
837 HYPERGLYCAEMIA 48 0.0013
838 BONE DISORDER 24 0.0013
839 EATING DISORDER 28 0.0013
840 BLOOD GLUCOSE DECREASED 63 0.0013
841 DIABETES MELLITUS 100 0.0013
842 DEPRESSION 298 0.0013
843 RASH 566 0.0013
844 PANCREATITIS 68 0.0013
845 HEPATIC FUNCTION ABNORMAL 48 0.0013
846 SPEECH DISORDER 67 0.0013
847 DYSARTHRIA 48 0.0013
848 THERAPEUTIC PRODUCT EFFECT DECREASED 57 0.0013
849 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
850 INFLAMMATION 65 0.0013
851 FREQUENT BOWEL MOVEMENTS 34 0.0013
852 SENSORY DISTURBANCE 20 0.0012
853 DRUG ERUPTION 22 0.0012
854 LUNG NEOPLASM MALIGNANT 51 0.0012
855 NEUROPATHY PERIPHERAL 116 0.0012
856 PRODUCT DOSE OMISSION ISSUE 358 0.0012
857 FRACTURE 23 0.0012
858 BALANCE DISORDER 103 0.0012
859 FULL BLOOD COUNT DECREASED 24 0.0012
860 GLYCOSYLATED HAEMOGLOBIN INCREASED 30 0.0012
861 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 84 0.0012
862 CRYING 42 0.0012
863 RASH ERYTHEMATOUS 55 0.0011
864 IRRITABILITY 69 0.0011
865 PRURITUS 434 0.0011
866 COMPLETED SUICIDE 94 0.0011
867 IMPAIRED HEALING 37 0.0011
868 ORAL PAIN 25 0.0011
869 THERAPEUTIC RESPONSE UNEXPECTED 50 0.0011
870 DEPRESSED LEVEL OF CONSCIOUSNESS 44 0.0011
871 FUNGAL INFECTION 37 0.0011
872 INCREASED APPETITE 21 0.0011
873 HYPERSENSITIVITY 204 0.0011
874 FEMUR FRACTURE 34 0.0011
875 SUICIDAL IDEATION 100 0.0011
876 PRODUCT PRESCRIBING ERROR 26 0.0011
877 HALLUCINATION, VISUAL 23 0.0011
878 EPILEPSY 33 0.0011
879 TOOTH DISORDER 24 0.0011
880 DEEP VEIN THROMBOSIS 70 0.0011
881 TOOTH LOSS 22 0.0011
882 PROTEINURIA 20 0.0011
883 URINARY RETENTION 35 0.0010
884 TYPE 2 DIABETES MELLITUS 35 0.0010
885 ELECTROCARDIOGRAM QT PROLONGED 37 0.0010
886 PNEUMONITIS 28 0.0010
887 ASTHMA 116 0.0010
888 IRRITABLE BOWEL SYNDROME 22 0.0010
889 SKIN IRRITATION 47 0.0010
890 ADVERSE DRUG REACTION 92 0.0010
891 ILL-DEFINED DISORDER 61 0.0010
892 NEOPLASM MALIGNANT 67 0.0010
893 TREATMENT FAILURE 82 0.0010
894 ARTHROPATHY 55 0.0010
895 MOBILITY DECREASED 71 0.0010
896 PSYCHOTIC DISORDER 29 0.0010
897 ANAPHYLACTIC REACTION 54 0.0010
898 APPLICATION SITE PRURITUS 22 0.0010
899 PRODUCT AVAILABILITY ISSUE 22 0.0010
900 EXTRA DOSE ADMINISTERED 39 0.0010
901 DIABETIC KETOACIDOSIS 23 0.0010
902 DERMATITIS 20 0.0010
903 JOINT STIFFNESS 25 0.0010
904 MOOD SWINGS 30 0.0009
905 EYE IRRITATION 54 0.0009
906 HEPATITIS 24 0.0009
907 IMPAIRED WORK ABILITY 20 0.0009
908 LACTIC ACIDOSIS 30 0.0009
909 PRURITUS GENERALISED 20 0.0009
910 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
911 BLOOD GLUCOSE INCREASED 172 0.0009
912 DRUG ADMINISTRATION ERROR 28 0.0009
913 PRODUCT USE IN UNAPPROVED INDICATION 226 0.0009
914 SKIN LESION 25 0.0009
915 ABNORMAL BEHAVIOUR 36 0.0009
916 MENTAL IMPAIRMENT 22 0.0009
917 CARDIOVASCULAR DISORDER 23 0.0009
918 DRY EYE 45 0.0009
919 NIGHTMARE 31 0.0009
920 DRY SKIN 119 0.0009
921 DYSGEUSIA 66 0.0009
922 MUSCULOSKELETAL STIFFNESS 76 0.0009
923 OVERDOSE 185 0.0009
924 FEAR 23 0.0009
925 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 22 0.0009
926 OSTEONECROSIS 28 0.0009
927 EYE DISORDER 28 0.0009
928 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 153 0.0008
929 DEVICE DIFFICULT TO USE 56 0.0008
930 INCORRECT DOSE ADMINISTERED 192 0.0008
931 INCORRECT DOSE ADMINISTERED BY DEVICE 22 0.0008
932 PSORIATIC ARTHROPATHY 34 0.0008
933 BONE DENSITY DECREASED 26 0.0008
934 ANGER 28 0.0008
935 FIBROMYALGIA 20 0.0008
936 VISUAL ACUITY REDUCED 27 0.0008
937 RASH GENERALISED 21 0.0008
938 EXPOSURE VIA SKIN CONTACT 21 0.0008
939 SUICIDE ATTEMPT 49 0.0008
940 APPLICATION SITE ERYTHEMA 21 0.0008
941 URTICARIA 134 0.0008
942 VAGINAL HAEMORRHAGE 34 0.0008
943 HYPOTHYROIDISM 25 0.0008
944 ANAPHYLACTIC SHOCK 20 0.0008
945 NERVOUS SYSTEM DISORDER 24 0.0008
946 EMOTIONAL DISTRESS 90 0.0007
947 PLASMA CELL MYELOMA 29 0.0007
948 COLITIS ULCERATIVE 33 0.0007
949 MEDICATION ERROR 41 0.0007
950 BLOOD CHOLESTEROL INCREASED 34 0.0007
951 PROCEDURAL PAIN 20 0.0007
952 WHITE BLOOD CELL COUNT DECREASED 78 0.0007
953 DYSKINESIA 29 0.0007
954 THERAPEUTIC RESPONSE DECREASED 42 0.0007
955 EXPIRED PRODUCT ADMINISTERED 23 0.0007
956 NEEDLE ISSUE 20 0.0007
957 EMOTIONAL DISORDER 21 0.0007
958 FEBRILE NEUTROPENIA 45 0.0007
959 STOMATITIS 41 0.0007
960 DISEASE RECURRENCE 32 0.0007
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 132 0.0007
962 PROSTATE CANCER 52 0.0006
963 SKIN EXFOLIATION 54 0.0006
964 ALOPECIA 125 0.0006
965 CONVULSION 35 0.0006
966 PSORIASIS 77 0.0006
967 INJURY 41 0.0006
968 INFUSION RELATED REACTION 37 0.0006
969 INJECTION SITE ERYTHEMA 69 0.0006
970 ECZEMA 29 0.0006
971 WITHDRAWAL SYNDROME 23 0.0005
972 RHEUMATOID ARTHRITIS 59 0.0005
973 BLADDER CANCER 30 0.0005
974 INJECTION SITE PRURITUS 34 0.0005
975 NO ADVERSE EVENT 87 0.0005
976 UNDERDOSE 34 0.0005
977 PRODUCT QUALITY ISSUE 63 0.0005
978 LEUKOPENIA 23 0.0005
979 INJECTION SITE HAEMORRHAGE 36 0.0005
980 MULTIPLE SCLEROSIS 21 0.0004
981 SKIN BURNING SENSATION 31 0.0004
982 INJECTION SITE SWELLING 32 0.0004
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 29 0.0004
984 DERMATITIS ATOPIC 20 0.0004
985 ACCIDENTAL EXPOSURE TO PRODUCT 38 0.0004
986 MULTIPLE SCLEROSIS RELAPSE 25 0.0004
987 INJECTION SITE PAIN 107 0.0003
988 DRUG WITHDRAWAL SYNDROME 30 0.0003
989 BREAST CANCER 31 0.0003
990 DRUG DEPENDENCE 51 0.0003
991 ACNE 24 0.0003
992 INJECTION SITE REACTION 20 0.0003
993 NEUTROPENIA 30 0.0002
994 MALIGNANT NEOPLASM PROGRESSION 21 0.0002